Skip to main content
OpenTrials

Clinical trial condition

LGI1 Autoimmune Encephalitis

Explore clinical trials studying LGI1 Autoimmune Encephalitis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

LGI1 Autoimmune Encephalitis trial results

Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis

NCT05503264

Conditions
LGI1 Autoimmune Encephalitis, NMDAR Autoimmune Encephalitis
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC San Diego La Jolla, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • UCSF- Multiple Sclerosis Centre San Francisco, California, United States
View all 77 locations
View Trial Details

Related conditions